# Subcutaneous Implanted Apheresis Port
> **Product code: PTD** · Class II — Moderate Risk (510(k) clearance required) · General Hospital · 21 CFR 880.5965
## Classification
- **FDA Product Code:** PTD
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 880.5965
- **Review panel:** HO
- **Medical specialty:** General Hospital
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** Y
- **Third-party review:** N
## Definition

A subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis

## Market data
- **Cleared 510(k) submissions:** 3
- **Registered establishments:** 4
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=PTD)
---
*AI Analytics · CC0 1.0*